Evidence map›Paper›PMID 25311506›Full record

ArticleThe Journal of experimental medicine2014

microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.

Antoine Marcais, Rory Blevins, Johannes Graumann, Amelie Feytout, Gopuraja Dharmalingam, Thomas Carroll, Inês F Amado, Ludovica Bruno, Keunwook Lee, Thierry Walzer and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Posttranscriptional Events Orchestrate Immune Homeostasis of CD8Methods in molecular biology (Clifton, N.J.) · 2024
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Extracellular Vesicles From Perinatal Cells for Anti-inflammatory Therapy.Frontiers in bioengineering and biotechnology · 2021
    Review
  11. Low miR-16 expression induces regulatory CD4American journal of cancer research · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Role of MicroRNAs in Parkinson's Disease.International journal of molecular sciences · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 7 countries.

Antoine MarcaisLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK CIRI, International Center for Infectiology Research, Université de Lyon, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Ecole Normale Supérieure, 69007 Lyon, France.
Rory BlevinsLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Johannes GraumannDepartment of Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, 82152 Martinsried, Germany Weill Cornell Medical College in Qatar, Qatar Foundation, Education City, Doha, State of Qatar.
Amelie FeytoutLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Gopuraja DharmalingamLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Thomas CarrollLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Inês F AmadoUnité de Biologie des Populations Lymphocytaires, Department of Immunology, Institut Pasteur, and Centre National pour la Recherche Scientifique (Centre National de la Recherche Scientifique), URA1961, 75724 Paris, France Graduate Program in Areas of Basic and Applied Biology (GABBA), Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
Ludovica BrunoLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Keunwook LeeDepartment of Pathology, Microbiology, and Immunology and Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
Thierry WalzerCIRI, International Center for Infectiology Research, Université de Lyon, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Ecole Normale Supérieure, 69007 Lyon, France.
Matthias MannDepartment of Proteomics and Signal Transduction, Max-Planck Institute for Biochemistry, 82152 Martinsried, Germany.
Antonio A FreitasUnité de Biologie des Populations Lymphocytaires, Department of Immunology, Institut Pasteur, and Centre National pour la Recherche Scientifique (Centre National de la Recherche Scientifique), URA1961, 75724 Paris, France.
Mark BoothbyDepartment of Pathology, Microbiology, and Immunology and Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232 Department of Pathology, Microbiology, and Immunology and Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232.
Amanda G FisherLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK.
Matthias MerkenschlagerLymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK Lymphocyte Development Group and Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK matthias.merkenschlager@csc.mrc.ac.uk.
Nordic Lymphoma Group · DKImperial College London · GBMax Planck Institute of Biochemistry · DEUniversité Claude Bernard Lyon 1 · FRVanderbilt University · USInstitut Pasteur · FRUniversidade do Porto · PT

Funding

Medical Research Council MC_U120027516
6 · The paper itself

Abstract

T cell receptor (TCR) signals can elicit full activation with acquisition of effector functions or a state of anergy. Here, we ask whether microRNAs affect the interpretation of TCR signaling. We find that Dicer-deficient CD4 T cells fail to correctly discriminate between activating and anergy-inducing stimuli and produce IL-2 in the absence of co-stimulation. Excess IL-2 production by Dicer-deficient CD4 T cells was sufficient to override anergy induction in WT T cells and to restore inducible Foxp3 expression in Il2-deficient CD4 T cells. Phosphorylation of Akt on S473 and of S6 ribosomal protein was increased and sustained in Dicer-deficient CD4 T cells, indicating elevated mTOR activity. The mTOR components Mtor and Rictor were posttranscriptionally deregulated, and the microRNAs Let-7 and miR-16 targeted the Mtor and Rictor mRNAs. Remarkably, returning Mtor and Rictor to normal levels by deleting one allele of Mtor and one allele of Rictor was sufficient to reduce Akt S473 phosphorylation and to reduce co-stimulation-independent IL-2 production in Dicer-deficient CD4 T cells. These results show that microRNAs regulate the expression of mTOR components in T cells, and that this regulation is critical for the modulation of mTOR activity. Hence, microRNAs contribute to the discrimination between T cell activation and anergy.

Indexed as

AnimalsBase SequenceBinding SitesCD4-Positive T-LymphocytesClonal AnergyGene Expression RegulationHumansInterleukin-2Lymphocyte ActivationMiceMice, TransgenicMicroRNAsPhosphorylationProto-Oncogene Proteins c-aktReceptors, Antigen, T-CellRibonuclease IIIInterleukin-2MicroRNAsProto-Oncogene Proteins c-aktReceptors, Antigen, T-CellRibonuclease IIITOR Serine-Threonine Kinases

Identifiers

PMID25311506
PMCPMC4203951
OpenAlexW2166812762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.